Capsule Endoscopy in Patients With Malignant Melanoma

Prakoso, Emilia; Selby, Warwick S.
June 2007
American Journal of Gastroenterology;Jun2007, Vol. 102 Issue 6, p1204
Academic Journal
BACKGROUND: Although small bowel (SB) involvement is found at postmortem in 50–60% of melanoma patients, diagnosis is only made during life in 10% of cases. This study reports the findings of capsule endoscopy (CE) in melanoma patients referred for investigation of suspected SB involvement. METHODS AND SUBJECTS: Eight men and five women with known or previous melanoma were referred for CE between December 2003 and September 2006. The indications were gastrointestinal bleeding (three), anemia (six), positive fecal occult blood test (one), abnormal imaging (two), and abdominal pain (one). RESULTS: CE showed SB metastases in five patients and excluded SB involvement in eight. All patients had previous investigations with either endoscopy, push enteroscopy, SB follow-through, CT scan, and/or PET scan. CE showed new lesions not detected by other investigation modalities. CE also ruled out SB metastases when other tests were nondiagnostic. All five patients with SB metastases detected underwent surgical resection. At follow-up after CE of a mean 8.4 months (1–23 months) and 4.9 months (0.25–10 months) after surgery, five patients had died, including three of those who had undergone resection of SB metastases. Seven patients were still alive, including two who had SB surgery. One patient was lost to follow-up. CONCLUSIONS: CE may detect the presence and extent of SB metastases in patients with melanoma more reliably than conventional investigations. It should be considered in the workup of melanoma patients with suspected SB disease.


Related Articles

  • Determinants of survival in patients with brain metastases from cutaneous melanoma. Staudt, M.; Lasithiotakis, K.; Leiter, U.; Meier, F.; Eigentler, T.; Bamberg, M.; Tatagiba, M.; Brossart, P.; Garbe, C. // British Journal of Cancer;4/12/2010, Vol. 102 Issue 8, p1213 

    Background:This retrospective study aimed to identify prognostic factors in patients with brain metastases from cutaneous melanoma.Methods:In all, 265 patients under regular screening according to valid national surveillance guidelines were included in the study. Kaplan–Meier analyses...

  • Pseudomesothelioma resulting from metastatic malignant melanoma. Luckraz, Heyman; Morgan, Matt; Gibbs, Allen R.; Butchart, Eric G. // European Journal of Cardio-Thoracic Surgery;Oct2005, Vol. 28 Issue 4, p655 

    Abstract: Isolated pleural metastatic melanoma is an uncommon clinical condition. Clinical diagnosis can be difficult and therapeutic options are limited. We describe a case where there was isolated pleural metastasis, 10 years following complete excision of a superficial melanotic lesion, which...

  • Primary pulmonary malignant melanoma: a clinicopathologic study of two cases. Li Gong; Xiao-Yan Liu; Wen-Dong Zhang; Shao-Jun Zhu; Li Yao; Xiu-Juan Han; Miao Lan; Yan-Hong Li; Wei Zhang // Diagnostic Pathology;2012, Vol. 7 Issue 1, p123 

    Abstract: Malignant melanoma involving the respiratory tract is nearly always metastatic in origin, and primary tumors are very rare. To our knowledge, about 30 cases have been reported in the English literature, one of which involved multiple brain metastases. Here, we report two cases of...

  • Prognostic Factors in Metastatic Melanoma Patients Treated with Biochemotherapy and Maintenance Immunotherapy. MINOR, DAVID R.; MOORE, DAN; KIM, CHRISTINE; KASHANI-SABET, MOHAMMED; VENNA, SURAJ S.; WEI WANG; BOASBERG, PETER; O'DAY, STEVEN // Oncologist;Oct2009, Vol. 14 Issue 10, p995 

    Background. With no U.S. Food and Drug Administration- approved standard therapy other than high-dose interleukin-2 and dacarbazine for metastatic melanoma, biochemotherapy has shown promise, with longterm survival in selected patients. We felt that the study of prognostic factors would...

  • Anorectal malignant melanoma: treatment with surgery or radiation therapy, or both. Moozar, Kouros L.; C. Shun Wong, Kouros L.; Couture, Jean // Canadian Journal of Surgery;Oct2003, Vol. 46 Issue 5, p345 

    Introduction: Anorectal malignant tumours are increasing in frequency for unknown reasons. Surgery is the principal treatment, and the role of adjuvant therapy has not been defined. We therefore decided to review the experience of the Princess Margaret Hospital in Toronto, a large tertiary care...

  • Gasless, video endoscopic transanal excision for carcinoid and laterally spreading tumors of the rectum. Nakagoe, T.; Ishikawa, H.; Sawai, T.; Tsuji, T.; Jibiki, M.; Nanashima, A.; Yamaguchi, H.; Yasutake, T. // Surgical Endoscopy;Aug2003, Vol. 17 Issue 8, p1298 

    Background: The aim of this study is to determine whether gasless, video endoscopic transanal-rectal tumor excision (gasless VTEM) is a valid treatment for rectal carcinoid and laterally spreading tumors (LST).Methods: Eighty-four patients with an adenoma,...

  • Excision Margins in High-Risk Malignant Melanoma. Thomas, J. Meirion; Newton-Bishop, Julia; A'Hern, Roger; Coombes, Gill; Timmons, Michael; Evans, Judy; Cook, Martin; Theaker, Jeffery; Fallowfield, Mary; O'Neill, Trevor; Ruka, Wlodek; Bliss, Judith M. // New England Journal of Medicine;2/19/2004, Vol. 350 Issue 8, p757 

    Background: Controversy exists concerning the necessary margin of excision for cutaneous melanoma 2 mm or greater in thickness. Methods: We conducted a randomized clinical trial comparing 1-cm and 3-cm margins. Results: Of the 900 patients who were enrolled, 453 were randomly assigned to undergo...

  • Malignant melanoma of the anorectum–a rare entity. Trzcinski, Radzislaw; Kujawski, Ryszard; Mik, Michal; Sygut, Andrzej; Dziki, Lukasz; Dziki, Adam // Langenbeck's Archives of Surgery;Aug2010, Vol. 395 Issue 6, p757 

    Primary anorectal melanoma is a rare entity with a poor prognosis accounting for approximately 0.1-4.6% of anal tumours and 0.5-1.6% of all melanomas. Almost 60% of patients have already disseminated disease at initial diagnosis. We report four cases of anorectal melanoma treated at our...

  • Local control of primary oropharyngeal malignant melanomas with limited tissue excision: a report of three cases. Ouml;ztürk, Özcan; Cansiz, Harun; Güzel, M.; Karakullukçu, Bariş; Özek, Hüsnü // European Archives of Oto-Rhino-Laryngology;Feb2005, Vol. 262 Issue 2, p89 

    Mucosal malignant melanomas are rare lesions, and they have different characteristics from their cutaneous counterparts. Since extended excisions of mucosal malignant melanomas located in the oropharyngeal region cause significant morbidity, limited surgical excision comes into consideration....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics